Welcome to MorphoSys

Founded nearly 20 years ago, MorphoSys is today one of the world's leading biotechnology companies. From a pure antibody platform enterprise, MorphoSys has matured into a renowned biopharmaceutical company with a rich pipeline of future therapeutic antibody products, a sustainable dual therapeutic business model and an additional venture in the research and diagnostic markets. The Company’s aim is to continue pushing the boundaries of antibody generation in the industry – for more effective, safer medicines and better diagnostics.